Cited by 170Neuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental DisordersProtease and Inhibitor Mechanisms

The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index; 1 of the 253 sources its claims cite were checked for support.

The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders

Open access
Wen, Teresa H., Binder, Devin K., Ethell, Iryna M., Razak, Khaleel A.·2018·Frontiers in Molecular Neuroscience

Abstract

Perineuronal nets (PNN) are extracellular matrix (ECM) assemblies that preferentially ensheath parvalbumin (PV) expressing interneurons. Converging evidence indicates that PV cells and PNN are impaired in a variety of neurological disorders. PNN development and maintenance is necessary for a number of processes within the CNS, including regulation of GABAergic cell function, protection of neurons from oxidative stress, and closure of developmental critical period plasticity windows. Understanding PNN functions may be essential for characterizing the mechanisms of altered cortical excitability observed in neurodegenerative and neurodevelopmental disorders. Indeed, PNN abnormalities have been observed in post-mortem brain tissues of patients with schizophrenia and Alzheimer's disease. There is impaired development of PNNs and enhanced activity of its key regulator matrix metalloproteinase-9 (MMP-9) in Fragile X Syndrome, a common genetic cause of autism. MMP-9, a protease that cleaves ECM, is differentially regulated in a number of these disorders. Despite this, few studies have addressed the interactions between PNN expression, MMP-9 activity and neuronal excitability. In this review, we highlight the current evidence for PNN abnormalities in CNS disorders associated with altered network function and MMP-9 levels, emphasizing the need for future work targeting PNNs in pathophysiology and therapeutic treatment of neurological disorders.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review synthesizes evidence that perineuronal nets (PNNs) around parvalbumin (PV) interneurons are abnormal in multiple neurological disorders, often alongside dysregulated MMP-9. It proposes that MMP-9-mediated PNN cleavage contributes to impaired PV cell function and cortical hyperexcitability, highlighting PNN/MMP-9 pathways as potential therapeutic targets.

Key findings

  • PNNs preferentially ensheath PV interneurons and are implicated in regulating GABAergic cell function, protecting neurons from oxidative stress, and closing developmental critical period plasticity; PNN abnormalities are reported in schizophrenia, Alzheimer’s disease, epilepsy, CNS injury/stroke, hearing loss, and Fragile X syndrome (FXS).
  • In FXS, Fmr1 knockout mice show delayed PNN development and increased MMP-9 activity in developing auditory cortex, mostly between P14 and P21; genetic reduction of MMP-9 normalized PV/PNN development and reversed auditory cortical neuron hyperresponsiveness. FXS is reported to occur in 1 in 4000 males and 1 in 8000 females.
  • In schizophrenia, post-mortem brains show reduced WFA-labeled PNN cells and reduced CSPGs and PV expression in prefrontal cortex; elevated plasma MMP-9 has been reported, and minocycline trials are cited as showing overall improvement in negative symptoms and executive functioning.
  • In Alzheimer’s disease, post-mortem hippocampus shows reduced PNN expression; PNN-ensheathed cells were more resistant to Aβ1-42 and iron-induced oxidative stress. Table 1 reports that in adult sensory cortices a majority of PV cells express PNNs, e.g., visual cortex ∼70% at 3–5 months, somatosensory layer 4 young adult ∼80%, and auditory cortex CBA young adult 50%.

Methods

  • Narrative review; no new experimental data are presented. It synthesizes published human post-mortem, rodent model, in vitro, EEG/electrophysiology, and clinical trial evidence.
  • Includes Table 1 compiling studies of PV cells enwrapped by PNNs across visual, somatosensory, and auditory cortices, with mouse strain, staining methods, and percentages by age and layer where available.
  • Main analysis is qualitative integration around a working hypothesis linking MMP-9 activity, PNN cleavage/reorganization, PV cell dysfunction, and altered network excitability.

Limitations

  • Stated in the paper: the precise role of PNNs in network function and development is not known; future studies should compare intrinsic and synaptic properties of the same cell types with and without PNNs; chABC likely has broader effects, so genetic removal of specific PNN components is needed; PNNs are heterogeneous and composition may be brain-region- and age-specific; mechanisms of PNN loss and restructuring in disease remain unclear.
  • Evident from the text: as a narrative review, there is no systematic search strategy or quantitative meta-analysis; causal direction between MMP-9, PNN changes, and excitability is often inferred from correlational animal and human data; therapeutic suggestions such as minocycline or MMP-9 inhibitors are based largely on preliminary or indirect evidence.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fnmol.2018.00270

Cites

209 of 209 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 Working hypothesis in which MMP-9 is necessary for normal PV cell function and consequently normal neuronal and network excitability (A). Top row: schematic of PV/PNN cells and cleavage of PNN by MMP-9. Middle row: single unit responses (each vertical line is an action potential in the post-stimulus time histogram) to sound stimulus (black bar under the abscissa) and spectral power of baseline EEGs. (B) Increased MMP-9 levels in disorders such as Fragile X Syndrome cause altered PNN formation/composition around PV cells. This may contribute to increased response to sensory stimuli and enhanced gamma power in baseline EEGs. The review argues that multiple neurological and neurodevelopmental disorders may include altered PV/PNN/MMP-9 interactions leading to circuit dysfunction. PV, parvalbumin; PNN, perineuronal nets; MMP-9, matrix metalloproteinase-9.
FIGURE 1 Working hypothesis in which MMP-9 is necessary for normal PV cell function and consequently normal neuronal and network excitability (A). Top row: schematic of PV/PNN cells and cleavage of PNN by MMP-9. Middle row: single unit responses (each vertical line is an action potential in the post-stimulus time histogram) to sound stimulus (black bar under the abscissa) and spectral power of baseline EEGs. (B) Increased MMP-9 levels in disorders such as Fragile X Syndrome cause altered PNN formation/composition around PV cells. This may contribute to increased response to sensory stimuli and enhanced gamma power in baseline EEGs. The review argues that multiple neurological and neurodevelopmental disorders may include altered PV/PNN/MMP-9 interactions leading to circuit dysfunction. PV, parvalbumin; PNN, perineuronal nets; MMP-9, matrix metalloproteinase-9.CC BY · PubMed Central
FIGURE 2 Structural composition of PNN. Lecticans are attached to a hyaluronan backbone via link proteins such as cartilage link protein and hyaluronan link proteins (not pictured). Hyaluronan synthase contributes to hyaluronan synthesis and anchors hyaluronan to the cell membrane. Tenascin promotes crosslinking of lecticans and helps maintain PNN structural integrity. PNN around PV cells may provide protection from redox dysregulation and oxidative stressors such as superoxide free radicals (O2-) and metal ions (Fe). In addition, PNNs may facilitate PV maturation through internalization of Otx2 homeoproteins and regulate PV cell excitability through accumulation of the immediate early gene and synaptic scaling molecule Narp (see Fragile X Syndrome). Narp, neuronal activity-regulated pentraxin; Otx2, orthodenticle homeoprotein 2.
FIGURE 2 Structural composition of PNN. Lecticans are attached to a hyaluronan backbone via link proteins such as cartilage link protein and hyaluronan link proteins (not pictured). Hyaluronan synthase contributes to hyaluronan synthesis and anchors hyaluronan to the cell membrane. Tenascin promotes crosslinking of lecticans and helps maintain PNN structural integrity. PNN around PV cells may provide protection from redox dysregulation and oxidative stressors such as superoxide free radicals (O2-) and metal ions (Fe). In addition, PNNs may facilitate PV maturation through internalization of Otx2 homeoproteins and regulate PV cell excitability through accumulation of the immediate early gene and synaptic scaling molecule Narp (see Fragile X Syndrome). Narp, neuronal activity-regulated pentraxin; Otx2, orthodenticle homeoprotein 2.CC BY · PubMed Central

Verification

Claims the paper makes

171 Not checked yet · 33 Own interpretation · 31 No basis given · 2 Own result · 1 Supported

Verify all 252 references — free account
  • Probably not a substantial claim. 44
  • It may state two separate claims as one. 55
88 of 88
  • The paper relies on this without support.

    Re-establishing neuronal plasticity is key for re-innervation and recovery after CNS injury and stroke.

    “In CNS injury and stroke, re-establishing neuronal plasticity appears to be key for re-innervation and recovery.”
  • The paper relies on this without support.

    MMP-9 is involved in PNN maintenance.

    “As MMP-9 is also involved in PNN maintenance”
  • The paper relies on this without support.

    Neurotrophins are necessary for neuronal growth and plasticity.

    “Neurotrophins are necessary for neuronal growth and plasticity”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 209 references

Research works printed but not linked: 5

  1. Berardi, 2004, Extracellular matrix and visual cortical plasticity: freeing the synapse., Neuron, 44, 905, 10.1016/j.neuron.2004.12.008 · DOI
  2. Golgi, 1893, Intorno all’origine del quarto nervo cerebrale e una questione istofisiologica che a questo argomento si collega., Rend. R Accademia Lincei, 2, 378
  3. Mercuri, 2000, Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity., J. Biol. Chem., 275, 33038, 10.1074/jbc.275.42.33038 · DOI · Paper page
  4. Ramón, 1897, Las células de cilindro-eje corto de la capa molecular del cerebro., Rev. Trim Micrográf., 2, 105
  5. Volk, 2000, Decreased GAD67 mRNA expression in a subset of prefrontal cortical GABA neurons in subjects with schizophrenia., Arch. Gen. Psychiatry, 57, 237, 10.1001/archpsyc.57.3.237 · DOI · Paper page

Cited by

Sorted by citations

See all 170

Metadata

Authors
Wen, T. H., Binder, D. K., Ethell, I. M., & Razak, K. A.
Affiliations
University of California, Riverside (US)
Corresponding author
  • Ethell, Iryna M.
  • Razak, Khaleel A.
Venue
Frontiers in Molecular Neuroscience
Published
2018-08-03
Volume
11
Pages
270-270
ISSN
1662-5099 (ISSN-L)
OpenAlex
W2886787141
Cited by
170
References
209
Citations by year
2026: 15 · 2025: 21 · 2024: 16 · 2023: 26 · 2022: 27 · 2021: 27 · 2020: 24 · 2019: 12 · 2018: 2
FWCI
2.10
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Molecular Neuroscience (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
National Institutes of Health (U54 HD082008)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Keywords
perineuronal nets, extracellular matrix, parvalbumin interneurons, MMP-9, fragile X syndrome, autism spectrum disorder, schizophrenia, Alzheimer's disease, cortical excitability, critical period plasticity, GABAergic inhibition, oxidative stress, neurodevelopmental disorders, neurodegenerative diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review